Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference27 articles.
1. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty;Circulation,1997
2. Comparison of two glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization;Topol;N Engl J Med,2001
3. Comparison of early invasive and conservative strategies in patients with unstable coronary syndrome treated with the glycoprotein IIb/IIIa inhibitor tirofiban;Cannon;N Engl J Med,2001
4. Suboptimal early inhibition of platelets by treatment with tirofiban and implication for coronary interventions;Kabbani;Am J Cardiol,2002
5. Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention;Herrmann;Am J Cardiol,2002
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction;Biomedicines;2024-09-04
2. Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction;JACC: Basic to Translational Science;2023-02
3. An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives;High Blood Pressure & Cardiovascular Prevention;2023-01-13
4. Mechanism and potential treatment of the “no reflow” phenomenon after acute myocardial infarction: role of pericytes and GPR39;American Journal of Physiology-Heart and Circulatory Physiology;2021-12-01
5. Desfechos em Pacientes com Fenômeno de No-Reflow Coronário e a Relação entre a Molécula-1 de Lesão Renal e o Fenômeno de No-Reflow Coronário;Arquivos Brasileiros de Cardiologia;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3